Brief: Athenex Presents Data From Oral Paclitaxel + Pembrolizumab Phase 1 Study At Esmo 2021

Athenex

16/09/2021 07:36

Sept 16 (Reuters) - Athenex Inc  ATNX.O :
    * ATHENEX PRESENTS DATA FROM ORAL PACLITAXEL + PEMBROLIZUMAB
PHASE
1 STUDY AT ESMO 2021

Source text for Eikon:  ID:nGNX1GpL2Y 
Further company coverage:  ATNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))